How the iLet Bionic Pancreas Could Revolutionize Type 1 Diabetes Management | The Brink
Type 1 diabetes is a 24/7/365 endeavor, experts say. Ed Damiano’s breakthrough automated insulin delivery device, the iLet, could change that.
Stay updated with breaking news from Beta Bionic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Type 1 diabetes is a 24/7/365 endeavor, experts say. Ed Damiano’s breakthrough automated insulin delivery device, the iLet, could change that.
ILet Bionic Pancreas, invented in a Boston University biomedical engineering lab, wins FDA clearance for people with type 1 diabetes.
A clinical trial finds a bionic pancreas device that autonomously delivers insulin in the right dose improves type 1 diabetes management.
Study in the New England Journal of Medicine finds iLet bionic pancreas is better at managing blood glucose levels than existing care options.
Beta Bionics' iLet bionic pancreas offers insulin therapy without some of the hurdles associated with treating diabetes.